CDSCO Panel Rejects Novo Nordisk Proposal to amend warning statement of Semaglutide Injection Dr. Divya Colin8 March 2025 5:15 PM ISTNew Delhi: Noting that post-marketing safety data in Indian patients is not presented, the Subject Expert Committee (SEC) functional under the Central...
AstraZeneca Pharma India secures CDSCO nod to import, sell Durvalumab for small cell lung cancer Ruchika Sharma8 March 2025 2:30 PM ISTBangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation...
Phase 3 study comparing Yesintek with Stelara in adult patients with chronic plaque psoriasis shows positive results: Biocon Biologics Ruchika Sharma8 March 2025 1:30 PM ISTBengaluru: BioconBiologics Ltd., a fully integrated global biosimilars company and subsidiary of Biocon Ltd. has announced the successful results...
Shilpa Medicare arm gets 1 UFSDA observation for Raichur Unit Ruchika Sharma8 March 2025 12:29 PM ISTKarnataka: Shilpa Medicare has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection with one observation...
Lupin unveils heart drug Rivaroxaban in US Ruchika Sharma8 March 2025 11:41 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has launched Rivaroxaban Tablets USP, 2.5 mg, following the final approval of...
Exemed Pharmaceutical Gets CDSCO Panel Nod To Manufacture Market Antidiabetic FDC Dr. Divya Colin7 March 2025 6:00 PM ISTNew Delhi: Exemed Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Alembic Pharma gets one procedural observation for Vadodara facility Ruchika Sharma7 March 2025 5:43 PM ISTVadodara: Alembic Pharma has announced that the United States Food and Drug Administration (USFDA) has concluded an inspection with...
Novartis Gets CDSCO Panel Nod To Study Antiparasitic drug LXE408 Dr. Divya Colin7 March 2025 5:15 PM ISTNew Delhi: Drug major Novartis has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Laurus Labs to invest Rs 83 crore in KRKA Pharma Ruchika Sharma7 March 2025 4:30 PM ISTHyderabad: Laurus Labs has announced that the Company has approved an investment of Rs 83 crore in KRKA Pharma, a joint venture of the Company."We...
Eris Lifesciences transfers 100% stake in 2 arms to Eris Therapeutics for Rs 861.9 crore Ruchika Sharma7 March 2025 2:30 PM ISTAhmedabad: Eris Lifesciences has announced that the Company has transferred 100 percent of its holdings in two wholly-owned subsidiaries to...
JnJ to discontinue Phase 3 VENTURA development program evaluating aticaprant for major depressive disorder Ruchika Sharma7 March 2025 1:30 PM ISTTitusville: Johnson & Johnson has announced the decision to discontinue the Phase 3 VENTURA development program evaluating aticaprant as an...
CDSCO nod to AstraZeneca to import, sell hyperkalaemia treatment drug in India Ruchika Sharma7 March 2025 12:30 PM ISTAstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation (CDSCO), Directorate General of...
